Mei Chen

17.3k citations
409 papers · 12.4k · 2 hit papers · h-index 59

Impact in

Papers in

Mei Chen

387 papers receiving 12.1k citations

Mei Chen's Hit Papers

Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1–Positive Endometrial Cancer: Results From the KEYNOTE-028 Study 2017 · 377 citations
3770+5+11Years since publication100200300

Peers

Mei Chen
Comparison fields: 5 of 195
  • Cell Biology 2.7k
  • Immunology and Allergy 716
  • Pathology and Forensic Medicine 2.1k
  • Rehabilitation 793
  • Genetics 1.2k
Replace Osamu Ishikawa with:
Osamu Ishikawa Japan
Gang Wang China
John J. Voorhees United States
Jae Ho Kim South Korea
Roland Kaufmann Germany
Wen G. Jiang United Kingdom
Jin‐Man Kim South Korea
Robert M. Hoffman United States
Nick Barker Singapore
Marco Presta Italy
Mei Chen relative to Osamu Ishikawa Japan Osamu Ishikawa's profile →
Citations per field
00.5×1.5×2.5×
Osamu Ishikawa · 1×
Citations per year

Countries citing papers authored by Mei Chen

Since Specialization
Citations

This map shows the geographic impact of Mei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei Chen more than expected).

Fields of papers citing papers by Mei Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei Chen. The network helps show where Mei Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Mei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mei Chen Line = papers co-authored together Mei Chen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 409 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1–Positive Endometrial Cancer: Results From the KEYNOTE-028 Study
Hit paper breakdown →
2017377
2 2013349
3
TANGO1 Facilitates Cargo Loading at Endoplasmic Reticulum Exit Sites
Hit paper breakdown →
2009282
4 1985277
5 1998272
6 2010266
7 2007233
8 2014226
9 2008178
10 2020151
11 2003149
12 2016149
13 2002144
14 1997140
15 2006133
16 1977124
17 2014123
18 1997115
19 2011108
20 2015107

About Mei Chen

Mei Chen is a scholar working on Molecular Biology, Cell Biology, Pathology and Forensic Medicine, Oncology and Cancer Research, having authored 409 papers that have together received 12.4k indexed citations. Recurring topics across this work include Skin and Cellular Biology Research (59 papers), Autoimmune Bullous Skin Diseases (50 papers), Heat shock proteins research (26 papers), Cellular Mechanics and Interactions (26 papers), Cell Adhesion Molecules Research (26 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (25 papers), Wound Healing and Treatments (21 papers) and Cell Image Analysis Techniques (14 papers). The work is most often cited by research in Cell Biology (2.7k citations), Immunology and Allergy (716 citations), Pathology and Forensic Medicine (2.1k citations), Rehabilitation (793 citations) and Genetics (1.2k citations). Mei Chen has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include David T. Woodley, Wei Li, Jianhua Fan, Douglas R. Keene, Edel A. O’Toole, Shengxi Guan, Chensheng Lu, David T. Woodley, Lawrence S. Chan and D. Porte. Their work appears in journals such as Journal of Investigative Dermatology, Journal of Biological Chemistry, Blood, Molecular Therapy and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact